Speed Was Never the Problem
This week, ScienceDaily ran a headline that surprised exactly no one in healthcare AI: generative AI can analyze medical data faster than human research teams. Of course it can. Speed has been a solved problem since the first SQL query outpaced a clipboard-wielding analyst. The real question — the one that determines whether your AI actually ships to production — is whether it's reliable enough to act on.
And that's where the conversation in healthcare AI needs to shift. Away from model selection. Away from fine-tuning debates. Toward something most healthcare data teams aren't even thinking about yet: inference-time compute optimization.
The Inference-Time Compute Revolution
If you've been heads-down in your dbt DAGs and Snowflake warehouses (respect), you might have missed the quiet revolution happening at the inference layer. Projects like OptiLLM have demonstrated that strategic application of compute at inference time — not during training — can dramatically improve model performance. We're talking about techniques like:
- Monte Carlo Tree Search (MCTS) — exploring multiple reasoning paths before committing to an answer
- Mixture of Agents (MOA) — routing queries to specialized models and synthesizing responses
- Best-of-N sampling — generating multiple candidate outputs and selecting the highest-quality result
- Chain-of-thought reflection — letting the model critique and refine its own reasoning
These aren't academic curiosities. They're production patterns. And they fundamentally change what's possible with off-the-shelf foundation models — no fine-tuning required.
Why Healthcare Can't Ignore This
Every vertical claims it needs accuracy. Healthcare actually does. When a model extracts a medication dosage from an unstructured clinical note, "close enough" means a patient safety event. When it classifies a diagnosis code for a claims submission, a wrong answer means audit exposure and revenue leakage.
Here's the problem: the traditional healthcare AI playbook — fine-tune a model on your proprietary clinical data — runs headfirst into PHI constraints. Every fine-tuning run is a data governance event. Every training dataset needs a BAA-covered compute environment. Every model artifact becomes a potential PHI vector that your compliance team has to track.
Inference-time compute sidesteps this entirely. You keep your foundation models generic. You keep your PHI in your governed data platform where it belongs — in Snowflake, behind role-based access, with full audit trails. And you push the intelligence to the orchestration layer that sits between your data and your models.
This is not a subtle distinction. It's an architectural choice that determines whether your healthcare AI program scales or drowns in compliance reviews.
Your Data Pipeline Needs a New Layer
Most healthcare data teams have built a solid modern foundation: EHR extracts flowing through dlt or Fivetran, transformed in dbt, served from Snowflake. Maybe you've bolted on a vector store for RAG. Maybe you're calling an LLM API from a Python script that someone wrote during a hackathon and now somehow runs in production.
That architecture is missing a critical layer: inference orchestration.
Inference orchestration is where you define how your models reason, not just what they reason about. It's where you specify that a clinical note extraction task should use best-of-3 sampling with a verification step. It's where you route a complex coding query through MCTS while sending a simple classification straight to a single inference call. It's where you implement the guardrails that make the difference between a demo and a deployed system.
This layer needs to be:
- Declarative — define inference strategies as configuration, not spaghetti code
- Observable — every reasoning path, every candidate output, every selection decision logged and queryable
- Cost-aware — MCTS on every API call will bankrupt you; you need intelligent routing based on task complexity
- PHI-conscious — the orchestration layer touches data, which means it needs the same governance controls as your data pipeline
If you're running dbt for transformation and Airflow or Dagster for orchestration, inference orchestration is the third leg of the stool. It deserves the same engineering rigor.
The Data Engineering Problem Nobody's Claiming
Right now, inference-time compute lives in ML engineering land. It's discussed at NeurIPS, implemented in research repos, and benchmarked on math competition problems. Meanwhile, healthcare data engineers — the people who actually understand the data, the governance requirements, and the production constraints — are nowhere near this conversation.
That needs to change. The organizations that will successfully deploy healthcare AI at scale won't be the ones with the best models. They'll be the ones whose data teams treat inference orchestration as a first-class pipeline component — versioned, tested, monitored, and governed with the same discipline they bring to their dbt projects.
The gap between "AI analyzes medical data fast" and "AI analyzes medical data reliably enough to act on" isn't a model problem. It's an infrastructure problem. And infrastructure is what data engineers build.
So the question isn't whether your team is experimenting with LLMs. Everyone is. The question is whether you've claimed inference-time compute as part of your data platform's responsibility — or whether you're still waiting for the ML team to figure it out.